Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism-Reference-Cited by-同舟云学术

Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism

Published:2001-11 Issue:5 Volume:250 Page:406-414
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Vestergaard H.,Lund S.,Pedersen O.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2796.2001.00898.x/fullpdf

Reference27 articles.

1. 1 DE Moller, and S. O'Rahilly, Syndromes of severe insulin resistance: clinical and pathophysiological features . In: Moller DE, ed.Insulin Resistance. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley & Sons, 1993; 49-81.

2. Insulin Resistance and the Prevention of Diabetes Mellitus

3. Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

4. Surgical removal of visceral fat reverses hepatic insulin resistance.

5. 5 G Grunberger, WM Weston, R Patwardhan, and EB. Rappaport, Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes . Diabetes1999 ; 48 (Suppl. 1):A 102.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: A case of Rabson–Mendenhall syndrome: long-term follow-up and therapeutic management with empagliflozin;Frontiers in Genetics;2024-06-24

2. SGLT2i Improves Glycemic Control in Patients With Congenital Severe Insulin Resistance;Pediatrics;2022-06-02

3. Identification of a Novel Mutation in Patients with Type A Insulin Resistance Syndrome;Human Heredity;2022

4. Glimepiride treatment in a patient with type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene;Journal of Diabetes Investigation;2018-03-24

5. Diagnostic and management challenges from childhood, puberty through to transition in severe insulin resistance due to insulin receptor mutations;Pediatric Diabetes;2017-01-17